NCT05675124

Brief Summary

The investigator conduct a randomized clinical trial for the needlescopic and conventional laparoscopic adrenalectomy to assess whether mini laparoscopic adrenalectomy is better than conventional laparoscopic adrenalectomy in terms of pain, complication rate , and wound cosmetics

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Feb 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Feb 2023Dec 2026

First Submitted

Initial submission to the registry

August 19, 2022

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 9, 2023

Status Verified

January 1, 2023

Enrollment Period

3.3 years

First QC Date

August 19, 2022

Last Update Submit

January 5, 2023

Conditions

Keywords

Visual Analogue ScalePost Operative PainDosage of analgesicCosmetic

Outcome Measures

Primary Outcomes (1)

  • Timing that two consecutive VAS less than 3 points

    Timing that two consecutive VAS less than 3 points after operation * The nurse for pain assessement would not know the allocation of the patient to this trial arms * Wound pain was assessed on a visual analogue scale (VAS) from 0 (none) to 10 (worst)

    up to 1 month postoperatively

Secondary Outcomes (1)

  • Cumulative morphine dosing

    Right after adrenalectomy until the morning of post-op Day 2 ( before the wound dressing change)

Study Arms (2)

Needlescopic laparoscopic adrenalectomy

EXPERIMENTAL

Needlescopic laparoscopic surgery refers to the use of instruments with a diameter of less than or equal to 3 mm for laparoscopic surgery.

Device: Needlescopic laparoscopic adrenalectomy

conventional laparoscopic adrenalectomy

ACTIVE COMPARATOR

a 12 mm camera port ,and two additional (left anterior axillary line and left midclavicular line; for left tumors) or three additional(right anterior axillary line, right midclavicular line, and subxiphoid; for right tumors) 5 mm working ports along the ipsilateral subcostal were created regionally.

Device: conventional laparoscopic adrenalectomy

Interventions

Compared with traditional laparoscopic surgery using 5-12 mm instruments, the wound of needlescopic laparoscopic surgery is smaller. Postoperative pain and recovery are also better than traditional laparoscopic surgery.

Needlescopic laparoscopic adrenalectomy

conventional laparoscopic adrenalectomy

conventional laparoscopic adrenalectomy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over the age of 20 years old.
  • Primary aldosteronism with unilateral adrenal lesions smaller than 4 cm
  • Indications for laparoscopic surgery.
  • Informed consent

You may not qualify if:

  • Over 80 years old
  • Suspected adrenal malignancy or pheochromocytoma
  • Other concurrent surgery
  • Patients who underwent bilateral adrenal tumor resection at the same time
  • History of peritonitis or having undergoing major ipsilateral abdominal surgery.
  • American Society of Anesthesiologists (ASA) Class III or IV (with severe cardiovascular disease, uncontrolled hypertension, diabetes, chronic pulmonary obstructive pulmonary disease, morbid obesity (BMI \> 40), dialysis patients, myocardial infarction, stroke, coronary artery disease, liver or coagulation dysfunction, etc.)
  • Opioid addiction
  • Patient have side effects from taking of acetaminophen, celecoxib or opioids
  • Acute intoxication of alcohol, sleep aids, anesthetics, centrally acting analgesics, opium or psychotropic drugs has occurred.
  • Patients using monoamine oxidase inhibitors (MAOIs) concurrently or within the past 14 days.
  • Patients with chronic pain or respiratory depression (such as chronic obstructive pulmonary disease)
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

Location

Related Publications (2)

  • Liao CH, Lai MK, Li HY, Chen SC, Chueh SC. Laparoscopic adrenalectomy using needlescopic instruments for adrenal tumors less than 5cm in 112 cases. Eur Urol. 2008 Sep;54(3):640-6. doi: 10.1016/j.eururo.2007.12.028. Epub 2007 Dec 26.

    PMID: 18164803BACKGROUND
  • Chueh SC, Chen J, Chen SC, Liao CH, Lai MK. Clipless laparoscopic adrenalectomy with needlescopic instruments. J Urol. 2002 Jan;167(1):39-42; discussion 42-3. doi: 10.1016/s0022-5347(05)65378-5.

    PMID: 11743271BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jeff Chueh

    Dep. of Urology, NTUH

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeff Chueh, Director, Dep. of Urology, NTUH

CONTACT

Chu-wen Fang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2022

First Posted

January 9, 2023

Study Start

February 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 9, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations